In the New England Journal of Medicine, Garvey and colleagues [5] report the results of the REDEFINE 1 trial, a 68-week, phase 3a double-blind, placebo-controlled and active-controlled trial evaluating the efficacy and safety of coadministered cagrilintide and semaglutide in adults with obesity [body mass index (BMI) 30 kg/m 2 ] or overweight (BMI 27 kg/m 2 ) with at least one weight-related comorbidity
More about Vitamins and Minerals Vitamin C Vitamin C is a water-soluble vitamin with many benefits for joint health, skin health, immune function, and supportive of collagen production
GLP-1 Receptor Agonists: Promising Therapeutic Targets for Alcohol Use Disorder
------------------------------------------------------------------------------------------------------------------------------------------- Eliminates excess water and drains the body
Its high concentration allows for economical use and maximum flexibility in daily supplementation
Semaglutide: Targets the GLP-1 pathway only Focuses on appetite regulation and fullness Tirzepatide: Targets both GLP-1 and GIP pathways May create a broader metabolic response Although this difference sounds technical, it can influence how patients respond to treatment
